Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

Newly published detailed clinical trial data show why Exelixis abandoned a plan to seek an FDA approval for a combination of ...

Patients treated with tyrosine kinase inhibitors received olanzapine to address adverse effects including nausea/vomiting, ...

Kidney stones are hard, mineral-based deposits that form in the kidneys due to an accumulation of substances like calcium, ...

In Europe alone, approximately 2 million people live with chronic inflammatory bowel diseases (IBD), and their incidence has ...

What is a kidney scan? A kidney scan is an imaging test that looks at your kidneys. Your health care provider can also see how well blood is flowing in your kidneys. A kidney scan is also called a ...

Getting a good night’s sleep is essential for overall health, and many people turn to sleep supplements to help them rest ...

This study explores the relationship of the neutrophil-to-high-density lipoprotein cholesterol ratio (NHR) with the risk of kidney stones in U.S. adults. Methods: The analysis involved 24,532 ...

Skyrizi and Rinvoq are expected to generate nearly $24 billion in combined sales in 2025, reflecting a $6 billion increase year-over-year. AbbVie raised its 2027 combined sales guidance for these ...

The decline was offset by sales of its newer arthritis drugs Skyrizi, which soared by 57% to $3.78 billion, and Rinvoq, which logged a 46% gain to $1.83 billion. Chief Executive Robert Michael ...

Today, a brief rundown of news involving Novartis and AbbVie, as well as updates from Biogen, Merck & Co. and Sanofi that you may have missed. Expected readouts in diabetes, cancer and depression ...

Image Source : FILE IMAGE Know the link between vitamin D supplements and kidney stones. Vitamin D is a fat-soluble vitamin and has a range of functions across multiple organ systems. Vitamin D ...